MACKENZIE FINANCIAL CORP - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2020$70,000
-10.3%
24,950
-30.7%
0.00%
Q3 2019$78,000
-31.0%
36,0000.0%0.00%
Q2 2019$113,000
-24.2%
36,000
-10.1%
0.00%
Q1 2019$149,000
+28.4%
40,0500.0%0.00%
Q4 2018$116,000
+10.5%
40,0500.0%0.00%
Q3 2018$105,000
+156.1%
40,050
+130.2%
0.00%
Q2 2018$41,000
-99.7%
17,400
-99.6%
0.00%
-100.0%
Q1 2018$14,599,000
+9.8%
4,965,762
+2.3%
0.04%
+15.6%
Q4 2017$13,298,000
-22.7%
4,853,362
-4.3%
0.03%
-65.6%
Q3 2017$17,201,000
+90.8%
5,074,015
+39.0%
0.09%
+86.0%
Q2 2017$9,017,000
-17.6%
3,650,544
-24.2%
0.05%
-21.9%
Q1 2017$10,938,000
+10.1%
4,818,609
+2.8%
0.06%
+6.7%
Q4 2016$9,938,000
-48.9%
4,687,825
-19.2%
0.06%
-50.4%
Q3 2016$19,433,000
+22.3%
5,800,811
+14.6%
0.12%
+34.4%
Q2 2016$15,894,000
+38.3%
5,061,825
+46.7%
0.09%
-13.5%
Q1 2016$11,489,000
+13.5%
3,450,178
+20.7%
0.10%
+65.1%
Q4 2015$10,123,0002,859,6000.06%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders